Amylyx Pharmaceuticals
Stock Forecast, Prediction & Price Target
Amylyx Pharmaceuticals (AMLX) stock Price Target by analysts
$8.25
Potential upside: 5.22%
Amylyx Pharmaceuticals price prediction
What is Amylyx Pharmaceuticals stock analysts` prediction?
Amylyx Pharmaceuticals stock forecast: Based on 4 Wall Street analysts` predicted price targets for Amylyx Pharmaceuticals in the last 3 months, the avarage price target is $8.25, with a high forecast of $NaN. The average price target represents a 5.22% change from the last price of $7.84.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Amylyx Pharmaceuticals stock Price Target by analysts
Full breakdown of analysts given Amylyx Pharmaceuticals price targets
Amylyx Pharmaceuticals Financial Estimates
Amylyx Pharmaceuticals Revenue Estimates
Amylyx Pharmaceuticals EBITDA Estimates
Amylyx Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $285K N/A | $22.23M 7700% | $380.78M 1612.93% | Avg: $114.53M Low: $111.68M High: $118.29M avg. -69.92% | Avg: $129K Low: $125.79K High: $133.24K avg. -99.88% | Avg: $4.46M Low: $4.35M High: $4.61M avg. 3360.72% | Avg: $19.19M Low: $18.71M High: $19.82M avg. 329.88% |
Net Income
% change YoY
| $-87.87M N/A | $-198.37M -125.73% | $49.27M 124.83% | Avg: $-89.14M Low: $-111.28M High: $-62.99M avg. -280.93% | Avg: $-73.89M Low: $-87.48M High: $-55.99M avg. 17.10% | Avg: $-50.56M Low: $-52.73M High: $-48.93M avg. 31.56% | Avg: $-46.54M Low: $-48.53M High: $-45.04M avg. 7.95% |
EBITDA
% change YoY
| $-82.68M N/A | $-201.34M -143.49% | $39.89M 119.81% | Avg: $-89.22M Low: $-92.16M High: $-87.01M avg. -323.67% | Avg: $-100.49K Low: $-103.80K High: $-98.00K avg. 99.88% | Avg: $-3.47M Low: $-3.59M High: $-3.39M avg. -3360.73% | Avg: $-14.95M Low: $-15.44M High: $-14.58M avg. -329.88% |
EPS
% change YoY
| -$1.52 N/A | -$2.98 -96.05% | $0.73 124.49% | Avg: -$1.32 Low: -$1.59 High: -$0.9 avg. -280.54% | Avg: -$1.04 Low: -$1.25 High: -$0.8 avg. 21.28% | Avg: -$0.72 Low: -$0.75 High: -$0.7 avg. 30.36% | Avg: -$0.67 Low: -$0.69 High: -$0.64 avg. 7.95% |
Operating Expenses
% change YoY
| $82.68M N/A | $220.57M 166.75% | $316.54M 43.50% | Avg: $3.85B Low: $3.75B High: $3.97B avg. 1116.80% | Avg: $4.33M Low: $4.23M High: $4.48M avg. -99.88% | Avg: $150.13M Low: $146.41M High: $155.07M avg. 3360.72% | Avg: $645.41M Low: $629.39M High: $666.64M avg. 329.88% |
FAQ
What is Amylyx Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -56.07% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -111.28M, average is -89.14M and high is -62.99M.
What is Amylyx Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 880.19% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $111.68M, average is $114.53M and high is $118.29M.
What is Amylyx Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -55.23% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$1.59, average is -$1.32 and high is $-0.9.
What is the best performing analyst?
In the last twelve months 4 analysts have been covering Amylyx Pharmaceuticals stock. The most successful analyst is Joel Beatty.